PMID: 15218957Jun 29, 2004Paper

Treatment of indolent non-Hodgkin's lymphoma with cladribine as single-agent therapy and in combination with mitoxantrone

International Journal of Hematology
James O ArmitageMathias Rummel

Abstract

The term indolent in describing a non-Hodgkin's lymphoma (NHL) generally refers to a group of B-cell NHLs composed of predominantly small cells that make up several categories, including follicular lymphoma, small lymphocytic lymphoma, and lymphoma of mucosa-associated lymphoid tissue. Most patients with follicular lymphoma respond to therapy, and the average survival time in large series is approximately 10 years. Patients who achieve a complete remission with initial treatment have an approximately 25% chance of remaining free of disease for 10 years. However, this means that more than 80% of patients will require salvage therapy. Cladribine is a newer purine analogue and is of particular interest because it is resistant to deamination by adenosine deaminase. It is cytotoxic to both proliferating and resting lymphocytes, making it an attractive agent for the treatment of indolent NHL. In this review article, we summarize the current treatment approaches for indolent NHL and the results of cladribine monotherapy studies in Japan and cladribine studies in Germany that have focused on a combination therapy with mitoxantrone. Cladribine is a potent inhibitor of DNA repair. The combination of a DNA-damaging agent with an inhibitor...Continue Reading

References

Dec 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·D A CarsonJ E Seegmiller
Mar 1, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A C KayL D Piro
Oct 1, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J LiliemarkG Juliusson
Nov 1, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·K BartonM J Ratain
Oct 17, 1992·Lancet·E Beutler
Apr 19, 1990·The New England Journal of Medicine·L D PiroE Beutler
Feb 1, 1985·The Journal of Clinical Investigation·S SetoD A Carson
Oct 1, 1986·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C J GallagherT A Lister
Nov 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·D A CarsonJ A Montgomery
Dec 6, 1984·The New England Journal of Medicine·S J Horning, S A Rosenberg
Apr 1, 1984·International Journal of Radiation Oncology, Biology, Physics·M K GospodarowiczT Chua
Apr 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G JuliussonG Tjønnfjord
Jan 1, 1995·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M A DimopoulosR Alexanian
Mar 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A SavenL D Piro
Apr 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M HoffmanK Rai
Oct 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B D ChesonJ M Sorensen
Apr 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G Juliusson, J Liliemark
Apr 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M P Mac Manus, R T Hoppe
Jul 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A SavenL Piro
Jan 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J F SeymourM J Keating
Feb 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P J BiermanJ O Armitage
Apr 19, 1997·Lancet·A WebbZ Dziewanowska
May 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R KurzrockM Talpaz
Jun 1, 1997·Japanese Journal of Clinical Oncology·K TobinaiY Ohashi
Mar 21, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D C BetticherT Cerny
Aug 15, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J O Armitage, D D Weisenburger
Aug 15, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P McLaughlinB K Dallaire
Sep 18, 1998·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J R AndersonD D Weisenburger
Aug 12, 1999·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P G Isaacson
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B D ChesonB Freidlin
Nov 30, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·N L HarrisC D Bloomfield
Mar 15, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J M VoseM S Kaminski
May 11, 2000·Blood Reviews·P J Bierman
Dec 29, 2000·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·J M VoseJ O Armitage
Oct 2, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M S KaminskiJ M Vose
Dec 1, 2001·International Journal of Radiation Oncology, Biology, Physics·R B WilderJ D Cox
Aug 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas E WitzigChristine A White
Sep 21, 2002·Lancet·Wolfgang FischbachHans Konrad Müller-Hermelink
Oct 16, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John D HainsworthF Anthony Greco
Mar 1, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Grant R GoodmanAlan Saven
May 2, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John D HainsworthUNKNOWN Minnie Pearl Cancer Research Network
May 2, 2003·The New England Journal of Medicine·Marta CrespoEmili Montserrat

❮ Previous
Next ❯

Citations

Mar 28, 2009·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Tadeusz RobakPawel Robak
Apr 12, 2008·Expert Review of Anticancer Therapy·Darren S Sigal, Alan Saven
Sep 13, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Owen A O'Connor
Sep 24, 2019·Saudi Journal of Medicine & Medical Sciences·Magdy KandilAhmed Sagheir
Dec 17, 2009·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Lauren C KleinJason N Berman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.